*  北京大学医学部机构知识库(IR@PKUHSC): Clinical comparison of ibutilide and propafenone for converting atrial flutter
Cardiovascular System & Cardiology ; Pharmacology & Pharmacy 关键词[WOS]: INTRAVENOUS IBUTILIDE ; ANTIARRHYTHMIC AGENT ; ... Cardiac & Cardiovascular Systems ; Pharmacology & Pharmacy 研究领域[WOS]: ... Clinical comparison of ibutilide and propafenone for converting atrial flutter[J]. CARDIOVASCULAR DRUGS AND THERAPY,2005,19(1): ...
  http://ir.bjmu.edu.cn/handle/400002259/56683
*  Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol. | Circulation
The use of membrane-active antiarrhythmic agents may be complicated by aggravation of existing arrhythmias or development of ... Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The ... were receiving class IC antiarrhythmic agents in an attempt to prevent inducibility of sustained ventricular tachycardia. New ... but it reproducibly suppressed drug-induced arrhythmias that appeared only after administration of the IC agents in each ...
  http://circ.ahajournals.org/content/80/6/1571
*  Flecainide - Wikipedia
As with all other antiarrhythmic agents, there is a risk of proarrhythmia associated with the use of flecainide. This risk is ... institution of cardiovascular support to avoid impending lethal arrhythmias. Modalities that have had success include ... Flecainide acetate (/flɛˈkeɪnaɪd/ flek-AY-nyde) is a class Ic antiarrhythmic agent used to prevent and treat tachyarrhythmias ( ... As with all class I antiarrhythmic agents, Flecainide increases the capture thresholds of pacemakers. Due to the narrow ...
  https://en.wikipedia.org/wiki/Flecainide
*  Disopyramide - Wikipedia
Mathur, P. P. (1972). "Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate". American Heart Journal ... It is a sodium channel blocker and therefore classified as a Class 1a anti-arrhythmic agent. Disopyramide has a negative ... Disopyramide does not act as a blocking agent for beta or alpha adrenergic receptors, but does have a significant negative ... These concerns about the drug must be viewed from the clinical perspective that disopyramide is generally the last agent that ...
  https://en.wikipedia.org/wiki/Disopyramide
*  Mexiletine Hydrochloride 10-mg/mL Oral Suspension
... class Ib antiarrhythmic agent, heart disease, cardiovascular disorders, Loyd V. Allen, Jr., PhD, RPh ... Wetting and/or Solubilizing Agents, Featured Excipient:. Allen Loyd V Jr Jul/Aug 2001. 310. Buy. ...
  http://www.ijpc.com/abstracts/abstract.cfm?ABS=2388
*  Vpt 311 General and Systemic Veterinary Pharamacology Tanuvas Lect Notes | Pharmacology | Cell Membrane
Drugs acting on cardiovascular system: cardiac glycosides, antiarrhythmic drugs, vasodilators and antihypertensive agents, ... ORAL HYPOGLYCEMIC AGENTS 88 . Sulphonyl ureas • These are agents that were first introduced as oral hypoglycemic agents. • ... ANTIBLOAT AGENTS Antibloat agents ( Viscosity altering agents) • Bloat is occurring due to excessive fermentation in rumen. • ... ANTIARRYTHMICS DRUGS Antiarrhythmics are agents used to control ectopic foci or reverse disorganized conduction of electrical ...
  https://www.scribd.com/doc/105615542/Vpt-311-General-and-Systemic-Veterinary-Pharamacology-Tanuvas-Lect-Notes
*  Patent US8173152 - Stabilized compositions containing alkaline labile drugs - Google Patents
Exemplary cardiovascular agents include nootropic agents, antiarrhythmic agents, calcium channel blocking agents, vasodilators ... nutritional agent, hematological agent, endocrine agent, metabolic agent, renal agent, genitourinary agent, respiratory agent, ... gastrointestinal agent, anti-infective agent, biologic agent, immunological agent, dermatological agent, ophthalmic agent, and ... anti-microbial agent, antimalarial agent, hormonal agent, contraceptive agent, sympathomimetic agent, diuretic agent, ...
  http://www.google.co.uk/patents/US8173152
*  Havard's Nursing Guide to Drugs : Adriana P. Tiziani : 9780729541411
CARDIOVASCULAR SYSTEM; Antianginal agents; Antiarrhythmic agents; Anticoagulants; Antihypertensive agents; Antimigraine agents ... Antibacterial agents; Antifungal agents; Antimalarial agents; Antimycobacterial agents; Antiprotozoal agents; Antiviral agents ... Anti-Alzheimer's agents; Antianxiety agents; Antidepressants; Antiemetic agents; Antiepileptics; Anti-Parkinson's agents; ... Antidiarrhoeal agents; Antiemetic agents; Antiulcer agents; Gastrointestinal agents (miscellaneous); Laxatives; Topical rectal ...
  https://www.bookdepository.com/Havards-Nursing-Guide-Drugs-Adrian-P-Tiziani/9780729541411?ref=bd_recs_1_1
*  Patent US4627836 - Cardiovascular prosthetic devices and implants with porous systems - Google Patents
Novel cardiovascular prosthetic devices or implants having many useful cardiovascular applications comprise a porous surface ... System for controlled release of antiarrhythmic agents. US5413599 *. Dec 13, 1993. May 9, 1995. Nippon Zeon Co., Ltd.. Medical ... Novel cardiovascular prosthetic devices or implants having many useful cardiovascular applications comprise a porous surface ... Novel cardiovascular prosthetic devices or implants having many useful cardiovascular applications comprise a porous surface ...
  http://www.google.com/patents/US4627836?dq=6,910,205
*  Petrem - FDA prescribing information, side effects and uses
Cardiovascular depression should be treated with plasma expanders, pressor agents, antiarrhythmic agents or other techniques as ... halogenated agents.. Warnings. sevoflurane, USP is a profound respiratory depressant. DUE TO THE RAPID AND DOSE DEPENDENT ... Sevoflurane, USP is an inhalational anesthetic agent for induction and maintenance of general anesthesia. The Minimum Alveolar ... The use of injectable induction agents without premedication has little effect on the concentrations of sevoflurane, USP ...
  https://www.drugs.com/pro/petrem.html
*  Sevoflurane for Animal Use - Drugs.com
Cardiovascular depression should be treated with plasma expanders, pressor agents, antiarrhythmic agents or other techniques as ... The use of injectable induction agents without premedication has little effect on the concentrations of sevoflurane required ... 5. Kazama, T. and Ikeda, K., The comparative cardiovascular effects of sevoflurane with halothane and isoflurane. J. ... Sevoflurane is an inhalational anesthetic agent for induction and maintenance of general anesthesia. The Minimum Alveolar ...
  https://www.drugs.com/vet/sevoflurane.html
*  Cardiorenal syndrome - Oxford Medicine
Cardiovascular drugs, in particular antiarrhythmic agents such as digoxin, sotalol, and flecainide, should be used with caution ... Renal disease is a potent cardiovascular risk factor and consequently cardiovascular disease is the most important cause of ... Cardiovascular drugs, in particular antiarrhythmic agents such as digoxin, sotalol, and flecainide, should be used with caution ... Concurrent renal and cardiovascular disease is common. Renal disease is a potent cardiovascular risk factor and consequently ...
  http://oxfordmedicine.com/view/10.1093/med/9780199204854.001.1/med-9780199204854-chapter-16514
*  Salimuzzaman Siddiqui - Wikipedia
Siddiqui's first breakthrough in research came when he successfully isolated an antiarrhythmic agent in 1931 from the roots of ... Many of these are still used worldwide for treatment of mental disorders and cardiovascular ailments, especially as ... antiarrhythmic agents in Brugada syndrome. Siddiqui was the first scientist to bring the anthelmintic, antifungal, ...
  https://en.wikipedia.org/wiki/Salimuzzaman_Siddiqui
*  What is Required to Gain Approval of Lipid Altering Drugs? | SpringerLink
Antiarrhythmic, and Hypolipidemic Agents. Developments in Cardiovascular Medicine, vol 100. Springer, Boston, MA. * DOI https ... Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents pp 249-251 , Cite as ... Part of the Developments in Cardiovascular Medicine book series (DICM, volume 100) ...
  https://link.springer.com/chapter/10.1007/978-1-4613-1605-3_17
*  John Giacomini, MD | Stanford Medicine Profiles
ANTIARRHYTHMIC AGENT AMIODARONE POSSESSES CALCIUM-CHANNEL BLOCKER PROPERTIES JOURNAL OF CARDIOVASCULAR PHARMACOLOGY Lubic, S. P ... The antiarrhythmic agent disopyramide comprises two enantiomers. In the present study, we examined the effects of the ... Professor of Medicine (Cardiovascular Medicine) at the Palo Alto Veterans Affairs Health Care System. Medicine - Cardiovascular ... In conclusion, agents that altered calcium influx through the L-type Ca2+ channel or inhibited mechanical activity affected ...
  https://med.stanford.edu/profiles/john-giacomini
*  CiNii 論文 - Chronotropic, Inotropic, Dromotropic and Coronary Vasodilator Effects of Bisaramil...
Comparison of Cardiovascular Effects of a Novel Class Ic Antiarrhythmic Agent, NIK-244, with Those of Flecainide in Isolated ... The cardiovascular effects of a new class I antiarrhythmic drug, bisaramil, were examined using canine isolated, blood-perfused ... Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations ... A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms Task force of ...
  https://ci.nii.ac.jp/naid/10008195458
*  Felodipine - Wikipedia
Volume 3: Cardiovascular Agents and Endocrines (6th ed.). Hoboken, N.J.: Wiley. ISBN 9780471270904. "Merck's Plendil ( ... Joshi, Gajanan S.; Burnett, James C.; Abraham, Donald J. (2003). "Cardiac Drugs: Antianginal, Vasodilators, Antiarrhythmic". In ...
  https://en.wikipedia.org/wiki/Felodipine
*  Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties | Circulation
Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The ... Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties. Charles Antzelevitch, ... Amiodarone is a potent antiarrhythmic agent used in the management of both atrial and ventricular arrhythmias. In addition to ... Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties. Charles Antzelevitch, ...
  http://circ.ahajournals.org/content/110/8/904
*  The Ankle-Brachial Index for Peripheral Artery Disease Screening and Cardiovascular Disease Prediction Among Asymptomatic...
Nano-scale drug delivery systems for antiarrhythmic agents.. Eur J Med Chem 2018; ... Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. ... QRISK2-2011 predicted cardiovascular disease in adult general practice patients Annals of Internal Medicine; 157 (8): JC4-12 ... An estimated 5% of U.S. persons aged 40 years or older without known cardiovascular disease (CVD) have an ABI of 0.9 or less (2 ...
  http://annals.org/aim/fullarticle/1733278/ankle-brachial-index-peripheral-artery-disease-screening-cardiovascular-disease-prediction
*  A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease | Annals...
Nano-scale drug delivery systems for antiarrhythmic agents.. Eur J Med Chem 2018; ... Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study Annals of Internal Medicine; 169 (4): ... In addition, the cardiovascular effects of daily doses of oral conjugated estrogen lower than 0.625 mg are unknown, and few ... When all cardiovascular risk factors were considered, the risk for major coronary events was lower among current users of ...
  http://annals.org/aim/article-abstract/714060/prospective-observational-study-postmenopausal-hormone-therapy-primary-prevention-cardiovascular-disease?doi=10.7326%2F0003-4819-133-12-200012190-00008
*  Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial - Full Text View - ClinicalTrials.gov
Cardiovascular death [ Time Frame: From date of enrollment until date of death ]. *Cardiovascular death or disabling stroke [ ... Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA). This study is ongoing, but not ... Other arrhythmias mandating anti-arrhythmic drug therapy (i.e. VT, VF). *Heritable arrhythmias or increased risk for torsade de ... Total mortality or cardiovascular hospitalization [ Time Frame: From date of enrollment until date of death or CV ...
  https://clinicaltrials.gov/ct2/show/NCT00911508?term=arrhythmia+OR+atrial+fibrillation+OR+ventricular+fibrillation+OR+tachycardia+OR+bradycardia&recr=Open&fund=01&rank=3
*  Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation - Full Text View -...
Adherence to anti-arrhythmic medication [ Time Frame: 1 year ]. Assessing whether patients stop taking anti-arrhythmic ... Cardiovascular Diseases. Pathologic Processes. Anti-Arrhythmia Agents. To Top. *For Patients and Families ... Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation. This study has been ... Education related to anti-arrhythmic therapy and monthly telephone follow-up to assess adherence to medication. ...
  https://clinicaltrials.gov/ct2/show/NCT01513031
*  Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation - Full Text View -...
Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation. The safety and ... Subject has any history of successful or unsuccessful treatment of AF with class I or III antiarrhythmic or sotalol with the ... Drug: Antiarrhythmic Drugs AAD therapy based on hospital clinical practice according to ESC Guidelines 2012 ... Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation.. ...
  https://clinicaltrials.gov/ct2/show/NCT01803438?term=palpitations&rank=16
*  Antiarrhythmic agent - Wikipedia
Damato, Anthony N. (1 July 1969). "Diphenylhydantoin: Pharmacological and clinical use". Progress in Cardiovascular Diseases. ... Class II agents are anti-sympathetic nervous system agents. Most agents in this class are beta blockers. Class III agents ... The class I antiarrhythmic agents interfere with the sodium channel. Class I agents are grouped by what effect they have on the ... The five main classes in the Vaughan Williams classification of antiarrhythmic agents are: Class I agents interfere with the ...
  https://en.wikipedia.org/wiki/Antiarrhythmic_agent
*  DailyMed - PERPHENAZINE- perphenazine tablet, film coated
If the patient is being treated with an anticonvulsant agent, increased dosage of that agent may be required when perphenazine ... Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden ... Metabolism of a number of medications, including antipsychotics, antidepressants, ß-blockers, and antiarrhythmics, occurs ... As with all antipsychotic agents, tardive dyskinesia may appear in some patients on long-term therapy or may appear after drug ...
  https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c76e98d-b8c3-441f-bac5-a9de6dc8f14f